The largest database of trusted experimental protocols
> Procedures > Therapeutic or Preventive Procedure > Operative Surgical Procedures

Operative Surgical Procedures

Operative Surgical Procedures encompass a broad range of surgical interventions performed to diagnose, treat, or manage various medical conditions.
This MeSH term includes all types of surgical operations, from minimally invasive procedures to complex, open surgeries.
Researchers and clinicians can utilize PubCompare.ai's AI-driven platform to streamline their surgical research workflow, locating relevant protocols from literature, preprints, and patents.
The advanced comparison tools can help identify the best protocols and products, enhancing reproducibility and accuracy.
Optimize your surgical research process and improve outcomes with the powerful tools offered by PubCopmare.ai.

Most cited protocols related to «Operative Surgical Procedures»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2008
Dietary Fiber Secure resin cement
For several of the data sets, the diffusion gradients are duplicated for opposing PE-directions. This offers a way to assess the performance of eddy and also to compare it to a commonly used existing method (eddy_correct in FSL) that uses FLIRT (Jenkinson and Smith, 2001 (link)), a 12-dof affine transformation and correlation ratio as a cost-function to register the diffusion weighted images to a b = 0 image. Two images acquired with the same diffusion gradient will have the same contrast and any difference between them should be due to differences in distortions and/or measurement error (noise). We therefore ran eddy separately on the data with the two different PE-directions and then calculated the sum-of-squared differences for paired diffusion weighted images.
Data acquired with different PE-directions also differ with respect to different susceptibility-induced distortions and if not corrected these would dominate any comparison between the images. We therefore used RGM and pairs of b = 0 (where there will be no eddy current-induced distortions) with different PE-directions to estimate the susceptibility-induced off-resonance field and applied that to the images using spline-interpolation and Jacobian modulation (see section Resampling the images). These “susceptibility-only corrected” pairs were the baseline against which the eddy and eddy_correct methods were compared. The eddy_correct method was modified to use spline interpolation and also to be able to incorporate the susceptibility-field from RGM so as to allow for a single resampling into a space corrected for susceptibility, eddy currents and subject movement in the same way that eddy does.
A series of tests was run on the FMRIB (data sets A and B ) and the early HCP data ( C ) to evaluate different settings for the options in eddy. As described above these tests were performed by running eddy separately on the A → P and the P → A (or L → R and R → L in the case of the HCP 3 T data ( C )) data and then compared pairwise to assess how well the correction worked. These settings were
Estimation of GP hyperparameters There are several different options for determining the hyperparameters for the Gaussian process that model the diffusion signal. These are maximum marginal likelihood (MML), leave-one-out cross validation (CV) and Geissers's surrogate predictive probability (GPP). For each method data was extracted from 1000 random brain voxels and used for the estimation. Note that this random voxel selection potentially introduces a run-to-run variability to the eddy results, but which can be turned off by specifying a seed at the command level.
Q-space smoothing The GP can be seen as a smoothing operation in Q-space. We tested different levels of increased smoothing by multiplying the error-variance estimates (hyperparameter of the GP) by values ranging from 1 (no additional smoothing) to 10.
Spatial smoothing Data and predictions were smoothed with a Gaussian filter with FWHM ranging from 0 to 5 mm. N.B. that the filtering is applied only during the estimation phase and not to the final resampled results.
EC model Different models for the EC-induced fields corresponding to first (four parameters), second (ten parameters) and third (20 parameters) order polynomials were tested. See Appendix A for a complete description of the different models.
Second level modeling The EC-parameters were fitted to a first or second order polynomial at the end of each iteration.
Joint modeling of multi-shell data When having multi-shell data one can either correct each shell independently or one can model (and correct) them all simultaneously. The latter option is potentially better because the Gaussian process is able to use data from one shell when making predictions about another shell (Andersson and Sotiropoulos, 2015 ). To test that, we corrected the HCP 3 T data ( C ) for each shell individually and also jointly for all four shells.
Full text: Click here
Publication 2016
Brain Diffusion Joints Movement Susceptibility, Disease Vibration
The GENCODE gene set is created by merging the results of manual and computational gene annotation methods. Manual gene annotation has two major modes of operation: clone-by-clone and targeted annotation. ‘Clone-by-clone’ annotation involves ‘walking’ across a genomic region, investigating the sequence, aligned expression data and computational predictions for each BAC clone. In doing so, an expert annotator investigates all possible genic features and considers all possible annotations and biotypes simultaneously. We believe this approach carries substantial advantages. For example, the decision to annotate a locus as protein-coding or pseudogenic benefits from being able to weigh both possibilities in light of all available evidence. This process helps prevent false positive and false negative misclassifications. Targeted annotation is designed to answer specific questions such as ‘is there an unannotated protein-coding gene in this position?’ Ranked target lists are generated by computational analysis based, for example, on transcriptomic data, shotgun proteomic data or conservation measures. Over the last two years mouse annotation has been dominated by the clone-by-clone approach while the human genome has been refined entirely via targeted reannotation except for the annotation of human assembly patches and haplotypes released by the Genome Reference Consortium (15 (link)), which take a clone-by-clone approach.
Over the last two years, we have focused on two broad areas: completing the first pass manual annotation across the entire mouse reference genome and a dedicated effort to improve the annotation of protein-coding genes in human and mouse.
We have completed the annotation of novel protein-coding genes, lncRNAs and pseudogenes, plus QC and updating previous annotation where necessary for mouse chromosomes 9, 10, 11, 12, 13, 14, 15, 16 and 17. These updates bring the fraction of the mouse genome with completed first pass manual annotation to approximately 97%. In addition, we have continued to work with the NCBI and Mouse Genome Informatics project at the Jackson Laboratory to resolve annotation differences for protein-coding, pseudogene and lncRNA loci. For protein-coding genes this is under the umbrella of the Consensus Coding Sequence (CCDS) project (16 (link)).
We have also manually investigated unannotated regions of high protein-coding potential identified by whole genome analysis using PhyloCSF (17 (link)) (a tool described in more detail below). In human, this led to the addition of 144 novel protein-coding genes and 271 pseudogenes (of which 42 were unitary pseudogenes). In mouse, we annotated orthologous loci for all but 11 of the 144 human protein-coding genes. We have also revisited the annotation of all olfactory receptor loci in both human and mouse, using RNAseq data to define 5′ and 3′ UTR sequences for ∼1400 loci. In human we have also targeted a ‘deep dive’ manual reannotation of genes on clinical panels for paediatric neurological disorders to identify missing functional alternative splicing. Incorporating second and third generation transcriptomic data, we reannotated ∼190 genes and added more than 3600 alternatively spliced transcripts, including ∼1400 entirely novel exons and an additional ∼30kb of CDS. We have also completed an effort to capture all recently described unannotated microexons (18 (link)) into GENCODE, and further added an additional 146 novel microexons mined from public SLRseq data (19 (link)).
As part of the CCDS collaboration with RefSeq, we have checked a large subset of human loci where there was disagreement over gene biotype. Similarly, we have checked all UniProt manually annotated and reviewed (i.e. Swiss-Prot) accessions that lack an equivalent in GENCODE. As a result, we added 32 novel protein-coding loci to GENCODE and rejected more than 200 putative coding loci. Finally, we are manually reviewing genes previously annotated as protein-coding, but with weak or no support based on a method incorporating UniProt, APPRIS, PhyloCSF, Ensembl comparative genomics, RNA-seq, mass spectrometry and variation data (20 (link),21 (link)). Of the 821 loci investigated to date, 54 have had their coding status removed while a further 110 potentially dubious cases remain under review.
The approach taken reflects in the kinds of updates captured in the annotation. For example, the targeted reannotation in human leads to the annotation of few novel protein-coding loci but many novel transcripts at updated protein-coding and lncRNA loci. Conversely, in mouse the emphasis on clone-by-clone annotation identifies many more novel loci and transcripts across a broader range of biotypes (Figure 1).
Full text: Click here
Publication 2018
3' Untranslated Regions Chromosomes, Human, Pair 9 Clone Cells Consensus Sequence Debility Exons Gene Annotation Gene Expression Profiling Gene Products, Protein Genes Genes, vif Genome Genome, Human Haplotypes Homo sapiens Mass Spectrometry Mice, Laboratory Nervous System Disorder NR4A2 protein, human Open Reading Frames Protein Annotation Proteins Pseudogenes Receptors, Odorant RNA, Long Untranslated RNA-Seq Staphylococcal Protein A TNFSF14 protein, human
The contaminant classification methods introduced here are implemented in the open-source decontam R package available from GitHub (https://github.com/benjjneb/decontam) and the Bioconductor repository [35 (link)]. The primary function, isContaminant, implements frequency- and prevalence-based contaminant identification that can be applied to a variety of sequence features including amplicon sequence variants (ASVs), operational taxonomic units (OTUs), taxonomic groups (e.g., genera), orthologous genes, metagenome-assembled-genomes (MAGs), and any other feature with quantitative per-sample relative abundance that is derived from marker-gene or metagenomics sequencing data (see also the “Discussion” section).
The primary input to isContaminant is a feature table of the relative abundances or frequencies of sequence features in each sample (e.g., an OTU table). In addition, isContaminant requires one of two types of auxiliary data for frequency- and prevalence-based contaminant identification, respectively: (1) quantitative DNA concentrations for each sample, often obtained during amplicon or shotgun sequencing library preparation in the form of a standardized fluorescence intensity (e.g., PicoGreen), and/or (2) sequenced negative control samples, preferably DNA extraction controls to which no sample DNA was added. Contaminants identified by decontam can be removed from the feature table with basic R functions described in decontam vignettes.
The isNotContaminant function supports the alternative use case of identifying non-contaminant sequence features in very low-biomass samples (C > S). isNotContaminant implements the prevalence method, but with the standard prevalence score P replaced with 1 − P, so low scores are now those associated with non-contaminants. isNotContaminant does not implement the frequency method for reasons described above and classifies very low prevalence samples conservatively, i.e., as contaminants, as is appropriate for the low-biomass regime.
Full text: Click here
Publication 2018
DNA Library Fluorescence Genes Genetic Diversity Genetic Markers Genome Metagenome PicoGreen
CRISPRFinder core routines were developed in Perl under Debian Linux. The input of the web tool is a genomic query sequence of length up to 67 Mb in ‘FASTA’ format. Possible locations of CRISPRs (consisting of at least one motif) are detected by finding maximal repeats. A maximal repeat (26 ) is a repeat that cannot be extended in either direction without incurring a mismatch. The total number of maximal repeats in a sequence of size n is linear (less than n) which is interesting since the computation may be done in linear time using a suffix-tree-based algorithm. A CRISPR pattern of two DRs and a spacer may be considered as a maximal repeat where the repeated sequences are separated by a sequence of approximately the same length.
The operation of the program can be divided into four main steps summarized in Figure 1: (Step 1) browsing the maximal repeats of length 23–55 bp interspaced by sequences of 25–60 bp, (Step 2) selecting the DR consensus according to a defined score taking into account the number of occurrences of the candidate DR in the whole genome and privileging internal mismatches between the DRs rather than mismatches in the first or the last nucleotides, (Step 3) defining candidate CRISPRs after checking if they fit CRISPR definition, (Step 4) eliminating residual tandem repeats.

CRISPR Finder flow chart. (Step 1) Browsing the maximal repeats to get possible CRISPR localizations using the Vmatch program. (Step 2) Consensus DR selection according to candidate occurrences and a score computation: the score privileges internal mismatches between direct repeats of a cluster rather than boundary mismatches. (Step 3) DR and spacers size check. (Step 4) Tandem repeats elimination using ClustalW for aligning spacers.

In the first step, maximal repeats are found by the software Vmatch (http://www.vmatch.de/), the upgrade of REPuter (22–24 ). Vmatch is based on a comprehensive implementation of enhanced suffix arrays (27 ) which provides the power of suffix trees with lower space requirements. A one nucleotide mismatch is allowed permitting minimal CRISPRs with a single nucleotide mutation between DRs to be found. Hereafter, the obtained maximal repeats are grouped to define regions of possible CRISPRs with a display of consensus DR candidates related to each cluster.
The second step is aimed at retrieving the DR consensus of each cluster. The difficulty resides especially in the identification of boundaries, which is very important to extract the correct spacers and compare DRs. In fact, the consensus DR is selected as the maximal repeat which occurs the most in the whole underlying genome sequence with respect to the forward and the reverse complement directions (since two CRISPRs having the same DR consensus may be in opposite directions). Thus, ambiguity in the choice of a DR will be eliminated in the case of presence of similar DRs in other CRISPRs of the related genomic sequence. However, if occurrence numbers are equal, more than a single DR consensus candidate are kept and later compared. Given a candidate consensus DR, the pattern search program fuzznuc of the EMBOSS package (28 (link)) is applied to get DRs’ positions in the related cluster. As the first or the last DR in a CRISPR may be diverged/truncated, a mismatch of one-third of the DR length is allowed between the flanking DRs and the candidate consensus DR, whereas smaller nucleotide differences are allowed between the other DRs to take into account possible single mutations. In case of multiple DR candidates, a score is computed and the best one (minimum) is picked. This score favours candidates which are encountered more frequently, rather than consensus DR showing less internal mismatches.
Once the DR consensus is determined, the corresponding spacers (Step 3) are extracted according to the DR boundaries determined previously. The spacer length is not allowed to be shorter than 0.6 or longer than 2.5 times the DR length. These sizes are in the range of CRISPRs described in the literature.
The last step consists in discarding false CRISPRs. Therefore, tandem repeats are eliminated by comparing the consensus DR with the spacer if there is only one spacer, or by comparing spacers between each other. The comparison is done with the CLUSTALW program (29 (link)) and the percentage of identity between spacers is not allowed to exceed 60%. Finally, candidates having at least three motifs and at least two exactly identical DRs are considered as confirmed CRISPRs. The remaining candidates are considered as questionable. These should be critically investigated by, for example, checking for intraspecies size variation of the locus.
Publication 2007
Clustered Regularly Interspaced Short Palindromic Repeats Direct Repeat Genome Mutation Nucleotides Repetitive Region Tandem Repeat Sequences Trees

Most recents protocols related to «Operative Surgical Procedures»

Not available on PMC !

Example 18

A non-transitory computer readable medium storing computer readable instructions which, when executed, causes a machine to: control the operation of a plurality of illumination sources of a tissue sample wherein each illumination source is configured to emit light having a specified central wavelength; receive data from the light sensor when the tissue sample is illuminated by each of the plurality of illumination sources; calculate structural data related to a characteristic of a structure within the tissue sample based on the data received by the light sensor when the tissue sample is illuminated by each of the illumination sources; and transmit the structural data related to the characteristic of the structure to be received by a smart surgical device, wherein the characteristic of the structure is a surface characteristic or a structure composition.

While several forms have been illustrated and described, it is not the intention of the applicant to restrict or limit the scope of the appended claims to such detail. Numerous modifications, variations, changes, substitutions, combinations, and equivalents to those forms may be implemented and will occur to those skilled in the art without departing from the scope of the present disclosure. Moreover, the structure of each element associated with the described forms can be alternatively described as a means for providing the function performed by the element. Also, where materials are disclosed for certain components, other materials may be used. It is therefore to be understood that the foregoing description and the appended claims are intended to cover all such modifications, combinations, and variations as falling within the scope of the disclosed forms. The appended claims are intended to cover all such modifications, variations, changes, substitutions, modifications, and equivalents.

The foregoing detailed description has set forth various forms of the devices and/or processes via the use of block diagrams, flowcharts, and/or examples. Insofar as such block diagrams, flowcharts, and/or examples contain one or more functions and/or operations, it will be understood by those within the art that each function and/or operation within such block diagrams, flowcharts, and/or examples can be implemented, individually and/or collectively, by a wide range of hardware, software, firmware, or virtually any combination thereof. Those skilled in the art will recognize that some aspects of the forms disclosed herein, in whole or in part, can be equivalently implemented in integrated circuits, as one or more computer programs running on one or more computers (e.g., as one or more programs running on one or more computer systems), as one or more programs running on one or more processors (e.g., as one or more programs running on one or more microprocessors), as firmware, or as virtually any combination thereof, and that designing the circuitry and/or writing the code for the software and or firmware would be well within the skill of one of skill in the art in light of this disclosure. In addition, those skilled in the art will appreciate that the mechanisms of the subject matter described herein are capable of being distributed as one or more program products in a variety of forms, and that an illustrative form of the subject matter described herein applies regardless of the particular type of signal bearing medium used to actually carry out the distribution.

Instructions used to program logic to perform various disclosed aspects can be stored within a memory in the system, such as dynamic random access memory (DRAM), cache, flash memory, or other storage. Furthermore, the instructions can be distributed via a network or by way of other computer readable media. Thus a machine-readable medium may include any mechanism for storing or transmitting information in a form readable by a machine (e.g., a computer), but is not limited to, floppy diskettes, optical disks, compact disc, read-only memory (CD-ROMs), and magneto-optical disks, read-only memory (ROMs), random access memory (RAM), erasable programmable read-only memory (EPROM), electrically erasable programmable read-only memory (EEPROM), magnetic or optical cards, flash memory, or a tangible, machine-readable storage used in the transmission of information over the Internet via electrical, optical, acoustical or other forms of propagated signals (e.g., carrier waves, infrared signals, digital signals, etc.). Accordingly, the non-transitory computer-readable medium includes any type of tangible machine-readable medium suitable for storing or transmitting electronic instructions or information in a form readable by a machine (e.g., a computer).

As used in any aspect herein, the term “control circuit” may refer to, for example, hardwired circuitry, programmable circuitry (e.g., a computer processor comprising one or more individual instruction processing cores, processing unit, processor, microcontroller, microcontroller unit, controller, digital signal processor (DSP), programmable logic device (PLD), programmable logic array (PLA), or field programmable gate array (FPGA)), state machine circuitry, firmware that stores instructions executed by programmable circuitry, and any combination thereof. The control circuit may, collectively or individually, be embodied as circuitry that forms part of a larger system, for example, an integrated circuit (IC), an application-specific integrated circuit (ASIC), a system on-chip (SoC), desktop computers, laptop computers, tablet computers, servers, smart phones, etc. Accordingly, as used herein “control circuit” includes, but is not limited to, electrical circuitry having at least one discrete electrical circuit, electrical circuitry having at least one integrated circuit, electrical circuitry having at least one application specific integrated circuit, electrical circuitry forming a general purpose computing device configured by a computer program (e.g., a general purpose computer configured by a computer program which at least partially carries out processes and/or devices described herein, or a microprocessor configured by a computer program which at least partially carries out processes and/or devices described herein), electrical circuitry forming a memory device (e.g., forms of random access memory), and/or electrical circuitry forming a communications device (e.g., a modem, communications switch, or optical-electrical equipment). Those having skill in the art will recognize that the subject matter described herein may be implemented in an analog or digital fashion or some combination thereof.

As used in any aspect herein, the term “logic” may refer to an app, software, firmware and/or circuitry configured to perform any of the aforementioned operations. Software may be embodied as a software package, code, instructions, instruction sets and/or data recorded on non-transitory computer readable storage medium. Firmware may be embodied as code, instructions or instruction sets and/or data that are hard-coded (e.g., nonvolatile) in memory devices.

As used in any aspect herein, the terms “component,” “system,” “module” and the like can refer to a computer-related entity, either hardware, a combination of hardware and software, software, or software in execution.

As used in any aspect herein, an “algorithm” refers to a self-consistent sequence of steps leading to a desired result, where a “step” refers to a manipulation of physical quantities and/or logic states which may, though need not necessarily, take the form of electrical or magnetic signals capable of being stored, transferred, combined, compared, and otherwise manipulated. It is common usage to refer to these signals as bits, values, elements, symbols, characters, terms, numbers, or the like. These and similar terms may be associated with the appropriate physical quantities and are merely convenient labels applied to these quantities and/or states.

A network may include a packet switched network. The communication devices may be capable of communicating with each other using a selected packet switched network communications protocol. One example communications protocol may include an Ethernet communications protocol which may be capable permitting communication using a Transmission Control Protocol/Internet Protocol (TCP/IP). The Ethernet protocol may comply or be compatible with the Ethernet standard published by the Institute of Electrical and Electronics Engineers (IEEE) titled “IEEE 802.3 Standard”, published in December, 2008 and/or later versions of this standard. Alternatively or additionally, the communication devices may be capable of communicating with each other using an X.25 communications protocol. The X.25 communications protocol may comply or be compatible with a standard promulgated by the International Telecommunication Union-Telecommunication Standardization Sector (ITU-T). Alternatively or additionally, the communication devices may be capable of communicating with each other using a frame relay communications protocol. The frame relay communications protocol may comply or be compatible with a standard promulgated by Consultative Committee for International Telegraph and Telephone (CCITT) and/or the American National Standards Institute (ANSI). Alternatively or additionally, the transceivers may be capable of communicating with each other using an Asynchronous Transfer Mode (ATM) communications protocol. The ATM communications protocol may comply or be compatible with an ATM standard published by the ATM Forum titled “ATM-MPLS Network Interworking 2.0” published August 2001, and/or later versions of this standard. Of course, different and/or after-developed connection-oriented network communication protocols are equally contemplated herein.

Unless specifically stated otherwise as apparent from the foregoing disclosure, it is appreciated that, throughout the foregoing disclosure, discussions using terms such as “processing,” “computing,” “calculating,” “determining,” “displaying,” or the like, refer to the action and processes of a computer system, or similar electronic computing device, that manipulates and transforms data represented as physical (electronic) quantities within the computer system's registers and memories into other data similarly represented as physical quantities within the computer system memories or registers or other such information storage, transmission or display devices.

One or more components may be referred to herein as “configured to,” “configurable to,” “operable/operative to,” “adapted/adaptable,” “able to,” “conformable/conformed to,” etc. Those skilled in the art will recognize that “configured to” can generally encompass active-state components and/or inactive-state components and/or standby-state components, unless context requires otherwise.

The terms “proximal” and “distal” are used herein with reference to a clinician manipulating the handle portion of the surgical instrument. The term “proximal” refers to the portion closest to the clinician and the term “distal” refers to the portion located away from the clinician. It will be further appreciated that, for convenience and clarity, spatial terms such as “vertical”, “horizontal”, “up”, and “down” may be used herein with respect to the drawings. However, surgical instruments are used in many orientations and positions, and these terms are not intended to be limiting and/or absolute.

Those skilled in the art will recognize that, in general, terms used herein, and especially in the appended claims (e.g., bodies of the appended claims) are generally intended as “open” terms (e.g., the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” etc.). It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present. For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to claims containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (e.g., “a” and/or “an” should typically be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations.

In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should typically be interpreted to mean at least the recited number (e.g., the bare recitation of “two recitations,” without other modifiers, typically means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). In those instances where a convention analogous to “at least one of A, B, or C, etc.” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (e.g., “a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, etc.). It will be further understood by those within the art that typically a disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms unless context dictates otherwise. For example, the phrase “A or B” will be typically understood to include the possibilities of “A” or “B” or “A and B.”

With respect to the appended claims, those skilled in the art will appreciate that recited operations therein may generally be performed in any order. Also, although various operational flow diagrams are presented in a sequence(s), it should be understood that the various operations may be performed in other orders than those which are illustrated, or may be performed concurrently. Examples of such alternate orderings may include overlapping, interleaved, interrupted, reordered, incremental, preparatory, supplemental, simultaneous, reverse, or other variant orderings, unless context dictates otherwise. Furthermore, terms like “responsive to,” “related to,” or other past-tense adjectives are generally not intended to exclude such variants, unless context dictates otherwise.

It is worthy to note that any reference to “one aspect,” “an aspect,” “an exemplification,” “one exemplification,” and the like means that a particular feature, structure, or characteristic described in connection with the aspect is included in at least one aspect. Thus, appearances of the phrases “in one aspect,” “in an aspect,” “in an exemplification,” and “in one exemplification” in various places throughout the specification are not necessarily all referring to the same aspect. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner in one or more aspects.

Any patent application, patent, non-patent publication, or other disclosure material referred to in this specification and/or listed in any Application Data Sheet is incorporated by reference herein, to the extent that the incorporated materials is not inconsistent herewith. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.

In summary, numerous benefits have been described which result from employing the concepts described herein. The foregoing description of the one or more forms has been presented for purposes of illustration and description. It is not intended to be exhaustive or limiting to the precise form disclosed. Modifications or variations are possible in light of the above teachings. The one or more forms were chosen and described in order to illustrate principles and practical application to thereby enable one of ordinary skill in the art to utilize the various forms and with various modifications as are suited to the particular use contemplated. It is intended that the claims submitted herewith define the overall scope.

Full text: Click here
Patent 2024
Acoustics Character Conferences DNA Chips Electricity Enzyme Multiplied Immunoassay Technique Fingers Human Body Light Medical Devices Memory Mental Orientation Ocular Refraction Physical Examination Reading Frames Surgical Instruments Teaching Tissues Transmission, Communicable Disease Vision
Not available on PMC !

Example 151

[Figure (not displayed)]

To a solution of compound 662 (0.270 g, 0.177 mmol, 1.0 eq.) in DCM (6.0 mL) at r.t. was added TFA (2.0 mL) and stirred for 4 h. The mixture was diluted with anhydrous toluene and concentrated, this operation was repeated for three times to give yellow oil, which was purified on prep-HPLC (C18 column, mobile phase A: water, mobile phase B: acetonitrile, from 10% of B to 80% of B in 60 min). The fractions were pooled and lyophilized to give the title compound (172 mg, 83% yield). ESI m/z calcd for C57H90N11O13S [M+H]+: 1168.6, found: 1168.6.

Full text: Click here
Patent 2024
acetonitrile Anabolism High-Performance Liquid Chromatographies Toluene
Not available on PMC !

Example 34

The system of any of Examples 23 to 33, wherein the operation further comprises: performing inferences for a subset of the one or more subsequent inferences using the machine learning model and the received weight information; determining that results of the subset of the one or more subsequent inferences using the machine learning model and the quantized weight information are outside the threshold performance level relative to results of the subset of the one or more subsequent inferences using the machine learning model and the received weight information; and based on the determining, performing additional inferences using the machine learning model and the received weight information.

Full text: Click here
Patent 2024
Acclimatization
Not available on PMC !

Example 7

In operation, the medical device (1) may be removed from the expanded tissue using the insertion apparatus (65). The procedure includes:

    • making a small incision to expose the membrane-covered port (55) of the implanted medical device (1);
    • inserting the insertion apparatus (65) into the membrane-covered port (55);
    • securing the insertion apparatus (65) onto the balloon (5) and the substantially hollowed core (40);
    • deflating the balloon (5); and
    • removing the balloon (5) from the patient.

Full text: Click here
Patent 2024
Medical Devices Patients Tissue, Membrane Tissue Expansion Devices Tissues
Not available on PMC !

Example 158

[Figure (not displayed)]

To a solution of compound 671 (0.20 g, 0.349 mmol, 1.0 eq) in DCM (6.0 mL) at r.t. was added TFA (2.0 mL) and the reaction was stirred for 2 h, then diluted with anhydrous toluene and concentrated, this operation was repeated for three times to give the title compound as a yellow oil (165 mg, theoretical yield). ESI m/z calcd for C24H36N5O5 [M+H]+: 474.3, found: 474.3.

Full text: Click here
Patent 2024
Anabolism Toluene

Top products related to «Operative Surgical Procedures»

Sourced in United States, China, United Kingdom, Germany, Australia, Japan, Canada, Italy, France, Switzerland, New Zealand, Brazil, Belgium, India, Spain, Israel, Austria, Poland, Ireland, Sweden, Macao, Netherlands, Denmark, Cameroon, Singapore, Portugal, Argentina, Holy See (Vatican City State), Morocco, Uruguay, Mexico, Thailand, Sao Tome and Principe, Hungary, Panama, Hong Kong, Norway, United Arab Emirates, Czechia, Russian Federation, Chile, Moldova, Republic of, Gabon, Palestine, State of, Saudi Arabia, Senegal
Fetal Bovine Serum (FBS) is a cell culture supplement derived from the blood of bovine fetuses. FBS provides a source of proteins, growth factors, and other components that support the growth and maintenance of various cell types in in vitro cell culture applications.
Sourced in United States, China, Germany, United Kingdom, Spain, Australia, Italy, Canada, Switzerland, France, Cameroon, India, Japan, Belgium, Ireland, Israel, Norway, Finland, Netherlands, Sweden, Singapore, Portugal, Poland, Czechia, Hong Kong, Brazil
The MiSeq platform is a benchtop sequencing system designed for targeted, amplicon-based sequencing applications. The system uses Illumina's proprietary sequencing-by-synthesis technology to generate sequencing data. The MiSeq platform is capable of generating up to 15 gigabases of sequencing data per run.
Sourced in United States, China, United Kingdom, Germany, France, Australia, Canada, Japan, Italy, Switzerland, Belgium, Austria, Spain, Israel, New Zealand, Ireland, Denmark, India, Poland, Sweden, Argentina, Netherlands, Brazil, Macao, Singapore, Sao Tome and Principe, Cameroon, Hong Kong, Portugal, Morocco, Hungary, Finland, Puerto Rico, Holy See (Vatican City State), Gabon, Bulgaria, Norway, Jamaica
DMEM (Dulbecco's Modified Eagle's Medium) is a cell culture medium formulated to support the growth and maintenance of a variety of cell types, including mammalian cells. It provides essential nutrients, amino acids, vitamins, and other components necessary for cell proliferation and survival in an in vitro environment.
Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, Austria, Japan, Belgium, United Kingdom, Cameroon, China, Denmark, Canada, Israel, New Caledonia, Germany, Poland, India, France, Ireland, Australia
SAS 9.4 is an integrated software suite for advanced analytics, data management, and business intelligence. It provides a comprehensive platform for data analysis, modeling, and reporting. SAS 9.4 offers a wide range of capabilities, including data manipulation, statistical analysis, predictive modeling, and visual data exploration.
Sourced in United States, Germany, United Kingdom, China, Canada, France, Japan, Australia, Switzerland, Israel, Italy, Belgium, Austria, Spain, Gabon, Ireland, New Zealand, Sweden, Netherlands, Denmark, Brazil, Macao, India, Singapore, Poland, Argentina, Cameroon, Uruguay, Morocco, Panama, Colombia, Holy See (Vatican City State), Hungary, Norway, Portugal, Mexico, Thailand, Palestine, State of, Finland, Moldova, Republic of, Jamaica, Czechia
Penicillin/streptomycin is a commonly used antibiotic solution for cell culture applications. It contains a combination of penicillin and streptomycin, which are broad-spectrum antibiotics that inhibit the growth of both Gram-positive and Gram-negative bacteria.
Sourced in United States, China, Germany, Canada, United Kingdom, Japan, France, Italy, Morocco, Hungary, New Caledonia, Montenegro, India
Sprague-Dawley rats are an outbred albino rat strain commonly used in laboratory research. They are characterized by their calm temperament and reliable reproductive performance.
Sourced in Germany, France, United States, United Kingdom, Canada, Italy, Brazil, Belgium, Cameroon, Switzerland, Spain, Australia, Ireland, Sweden, Portugal, Netherlands, Austria, Denmark, New Zealand
Rompun is a veterinary drug used as a sedative and analgesic for animals. It contains the active ingredient xylazine hydrochloride. Rompun is designed to induce a state of sedation and pain relief in animals during medical procedures or transportation.
Sourced in United States, United Kingdom, Germany, China, France, Canada, Japan, Australia, Switzerland, Italy, Israel, Belgium, Austria, Spain, Brazil, Netherlands, Gabon, Denmark, Poland, Ireland, New Zealand, Sweden, Argentina, India, Macao, Uruguay, Portugal, Holy See (Vatican City State), Czechia, Singapore, Panama, Thailand, Moldova, Republic of, Finland, Morocco
Penicillin is a type of antibiotic used in laboratory settings. It is a broad-spectrum antimicrobial agent effective against a variety of bacteria. Penicillin functions by disrupting the bacterial cell wall, leading to cell death.

More about "Operative Surgical Procedures"

Operative Surgical Procedures encompass a wide range of surgical interventions used to diagnose, treat, and manage various medical conditions.
This broad term includes all types of surgical operations, from minimally invasive procedures to complex, open surgeries.
Researchers and clinicians can utilize PubCompare.ai's AI-driven platform to streamline their surgical research workflow, locating relevant protocols from literature, preprints, and patents.
The advanced comparison tools offered by PubCompare.ai can help identify the best surgical protocols and products, enhancing reproducibility and accuracy.
This can optimize the surgical research process and improve outcomes.
Discover how PubCompare.ai can streamline your surgical research by locating protocols from literature, preprints, and patents using their AI-driven platform.
The platform's powerful tools can assist in identifying the most suitable surgical protocols and products through advanced comparisons, boosting reproducibility and precision.
Optimize your surgical research workflow and enhance patient outcomes with the innovative solutions provided by PubCompare.ai.
Surgical research may also involve the use of various laboratory techniques and tools, such as the FBS (Fetal Bovine Serum) cell culture supplement, the MiSeq platform for DNA sequencing, and the DMEM (Dulbecco's Modified Eagle Medium) cell culture medium.
Additionally, researchers may utilize the TRIzol reagent for RNA extraction, SAS version 9.4 for statistical analysis, and antibiotics like Penicillin/streptomycin to prevent bacterial infections.
Animal models, such as Sprague-Dawley rats and the anesthetic Rompun, may also be employed in surgical research.